2025年4月28日晚间,药明康德发布一季度报告。根据报告显示,公司一季度整体收入96.5亿元,同比增长21%。值得注意的是,这是公司在新冠一次性需求消退后,公司营收表观数据重回双位数增长。与此同时,公司三个口径下的利润数据也均实现了双位数增长。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.